Hip Replacement Implant Systems Ineffective, Johnson & Johnson Recalls Products
Hip replacement surgery, although necessary in many instances, is an invasive procedure that many patients cannot even imagine going through again. After data from the National Joint Registry of England and Wales revealed that over a course of five years, approximately 12% of individuals receiving Johnson & Johnson’s DePuy Orthopaedics hip resurfacing system and about 13% percent of those receiving the acetabular system needed corrective surgery, a recall of the hip replacement products has been issued.
A patient requiring a second hip replacement procedure is not unheard of; however, the DePuy systems have been associated with an abnormally high proportion of individuals needing corrective surgery. For a patient to be faced with having to undergo corrective hip replacement surgery due to one of the recalled systems, he or she is likely to have endured difficulty walking and serious pain as a result of the ineffective product.
The Associated Press reports that this is Johnson & Johnson’s eleventh recall within one year, being announced only a few days after the company was given a government warning for allegedly marketing two different products unlawfully.
Defective medical devices, including implants like the hip replacement systems, can significantly alter an individual’s life on a physical, emotional, and financial level. While the recall of these products is important to help protect patients that may require a hip replacement, many patients have already suffered as a result.
Monheit is the managing lawyer at Monheit Law, outside Philadelphia, Pennsylvania. He has practiced law since 1989. Michael Monheit was the managing attorney of the law offices of Herbert Monheit — now Silverman and Fodera — a firm founded by... Michael Monheit→
